Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
Clinical trial NCT05673811 · COMPLETED
Trial details
- NCT number
- NCT05673811
- Sponsor
- Theriva Biologics SL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-10
- Primary completion
- 2025-03-28
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.